Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PI-88 in Hepatocellular Carcinoma After Hepatectomy
NCT00247728Phase 2Completed
- Sponsor
- Cellxpert Biotechnology Corp.
- Start
- Jun 2004
- Primary completion
- Jun 2008
- Modality
- Bivalent/Multivalent Binders
- Countries
- 1
01
Overview
A Phase 2 trial of Muparfostat in hepatocellular carcinoma (HCC), sponsored by Cellxpert Biotechnology Corp.. Started Jun 2004; status: completed.
02
Drugs
Muparfostat
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00247728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247728.